2269 fundamentals
An in-depth look to WUXI BIOLOGICS (CAYMAN) INC operating, investing, and financing activities
2269 free cash flow for H2 23 is 300.75 M HKD. For 2023, 2269 free cash flow was 494.54 M HKD and operating cash flow was 5.16 B HKD.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: HKD
TTM